This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Ethanol in the Prevention of Central Venous Catheter Infections

This study has been terminated.
(The non significative reduction of CRBSI adverse events,the need for a high frecuency of catheter manipulations)
Information provided by (Responsible Party):
Hospital General Universitario Gregorio Marañon Identifier:
First received: October 18, 2010
Last updated: July 16, 2012
Last verified: July 2012

In recent years, several new methods for treatment of catheter-related bloodstream infections (CRBSI) such as antibiotic or antiseptic lock-therapy have been developed with variable success [1-10].

Long-term tunnelled central venous catheters provide a reliable access for administration of chemotherapy, parenteral nutrition or haemodialysis. However, they are not free of complications such as bacteremia. The need to preserve these intra-vascular devices as long as is possible in patients in whom conventional treatment was failed makes emerge antibiotic lock-technique.

Ethanol lock-therapy was demonstrate her utility in this cases. But no study has yet been published using the ethanol lock-therapy as a prophylactic therapy in catheter related infections, neither her application in short-term CVCs.

Objectives: To investigate the value of a ethanol-lock solution in the prophylaxis of non-tunnelled short-term CVC related infections in a heart post-surgical intensive care unit (HPSICU).

Methods: An academic, prospective, randomized and controlled clinical trial is proposed. Patients at HPSICU who have a CVC more than 48 h will be randomized in two arms (ethanol-lock or control group with conventional measurements such as anticoagulants). In the follow-up period, we will register all necessary data to evaluate the end-points of study (CBRSI rate, catheter colonization rate, hospital stay, antimicrobial consume and adverse events due to ethanol).

Condition Intervention
Catheter Related Infection Drug: Ethanol Drug: Heparine

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Clinical Study of Ethanol Lock-therapy in the Prevention of Non-tunnelled, Short Term Central Venous Catheter Associated Infections

Further study details as provided by Hospital General Universitario Gregorio Marañon:

Primary Outcome Measures:
  • catheter infectionrelated incidence rates [ Time Frame: 2 years ]
    decrease on catheter infection related incidence rates in comparison to the institution incidence figures

Secondary Outcome Measures:
  • cathether bacteriaemia related rate [ Time Frame: 2 years ]
    versus Institution rate figures

  • antimicrobial consume [ Time Frame: 2 years ]
    Defined Diary Dosis(DDDs)in both arms

Enrollment: 200
Study Start Date: December 2009
Study Completion Date: February 2012
Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Ethanol
Every three day lock using Ethanol in all the lumen of the Catheter
Drug: Ethanol
Every three day lock using Ethanol(70%)in all the lumen(1ml/per lumen) of the Catheter
Active Comparator: Heparine
Every three day lock using Heparine in all the lumen of the Catheter
Drug: Heparine
Every three day lock using Heparin(Fibrilin TM) 3ml in all the lumen of the Catheter


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • older than 18 years old
  • Signed informed consent
  • central Venous catheter more than 48 hours placed

Exclusion Criteria:

  • pregnancy
  • denial Informed consent Form
  • ethanol intolerance
  • Liver cirrhosis
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01229592

Servicio de Microbiología y Enfermedades Infecciosas. Hospital GU Gregorio Marañon
Madrid, Spain, 28007
Sponsors and Collaborators
Hospital General Universitario Gregorio Marañon
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Hospital General Universitario Gregorio Marañon Identifier: NCT01229592     History of Changes
Other Study ID Numbers: EC07/90653
2007-007063-24 ( EudraCT Number )
Study First Received: October 18, 2010
Last Updated: July 16, 2012

Keywords provided by Hospital General Universitario Gregorio Marañon:

Additional relevant MeSH terms:
Communicable Diseases
Catheter-Related Infections
Anti-Infective Agents, Local
Anti-Infective Agents
Central Nervous System Depressants
Physiological Effects of Drugs processed this record on July 21, 2017